EC Number   |
Title |
Organism |
|---|
   6.2.1.45 | Direct catalysis of lysine 48-linked polyubiquitin chains by the ubiquitin-activating enzyme |
Escherichia coli |
| 6.2.1.45 | Expression, purification and characterization of human ubiquitin-activating enzyme, UBE1 |
Homo sapiens |
| 6.2.1.45 | Expression, purification, and crystal structure of N-terminal domains of human ubiquitin-activating enzyme (E1) |
Homo sapiens |
| 6.2.1.45 | High-yield expression in Escherichia coli and purification ofmouse ubiquitin-activating enzyme E1 |
Mus musculus |
| 6.2.1.45 | Homology modelling of human E1 ubiquitin activating enzyme |
Homo sapiens |
| 6.2.1.45 | Impaired nucleotide excision repair upon macrophage differentiation is corrected by E1 ubiquitin-activating enzyme |
Homo sapiens |
| 6.2.1.45 | Inhibitors of ubiquitin-activating enzyme (E1), a new class of potential cancer therapeutics |
Mus musculus |
| 6.2.1.45 | Inhibitors of ubiquitin-activating enzyme (E1), a new class of potential cancer therapeutics |
Homo sapiens |
| 6.2.1.45 | Largazole and its derivatives selectively inhibit ubiquitin activating enzyme (E1) |
Homo sapiens |
| 6.2.1.45 | Largazole and its derivatives selectively inhibit ubiquitin activating enzyme (E1) |
Schizosaccharomyces pombe |
